Medicare Enrolled

Dr. Derek Berberian, MD

Psychiatry · Ramsey, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
46 N CENTRAL AVE, Ramsey, NJ 07446
2015883491
In practice since 2012 (13 years)
NPI: 1346597200 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berberian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berberian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berberian

Dr. Derek Berberian is a psychiatry specialist in Ramsey, NJ, with 13 years of NPI registration. Based on federal Medicare data, Dr. Berberian performed 2,150 Medicare services across 350 unique beneficiaries.

Between the years covered by Open Payments, Dr. Berberian received a total of $7,686 from 34 pharmaceutical and/or device companies across 550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berberian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 4% volume in NJ $7,686 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,150
Medicare services
Top 4% in NJ for psychiatry
350
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~165 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
1,390 $109 $600
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
326 $70 $500
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
211 $56 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
143 $95 $600
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
61 $150 $800
Psychiatric diagnostic evaluation
A clinical assessment conducted by a psychiatrist to evaluate a patient's mental health status and determine a diagnosis.
19 $129 $800
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,686
Total received (2018-2024)
Avg $1,098/year across 7 years
Top 6% in NJ for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
550
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,686 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,817
2023
$2,087
2022
$1,082
2021
$747
2020
$543
2019
$695
2018
$717

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$389
ABBVIE INC.
$296
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$194
Alkermes, Inc.
$168
Tris Pharma Inc
$152
Otsuka America Pharmaceutical, Inc.
$96
Corium, LLC
$78
Axsome Therapeutics, Inc.
$71
Almatica Pharma LLC
$63
Takeda Pharmaceuticals U.S.A., Inc.
$63
Teva Pharmaceuticals USA, Inc.
$63
Vanda Pharmaceuticals Inc.
$49
PFIZER INC.
$36
Antares Pharma, Inc.
$34
Lundbeck LLC
$16
Neuronetics, Inc.
$16
Neurocrine Biosciences, Inc.
$16
Noven Therapeutics, LLC
$15
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$1,089
AbbVie Inc.
$681
Supernus Pharmaceuticals, Inc.
$650
Otsuka America Pharmaceutical, Inc.
$647
Alkermes, Inc.
$544
ABBVIE INC.
$528
Allergan Inc.
$402
Lundbeck LLC
$386
Teva Pharmaceuticals USA, Inc.
$371
Axsome Therapeutics, Inc.
$277
ITI, Inc.
$246
Novo Nordisk Inc
$213
Neurocrine Biosciences, Inc.
$213
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$194
Tris Pharma Inc
$181
Almatica Pharma LLC
$167
Corium, LLC
$162
Allergan, Inc.
$160
Antares Pharma, Inc.
$83
PFIZER INC.
$77
Vanda Pharmaceuticals Inc.
$49
Janssen Pharmaceuticals, Inc
$46
Ironshore Pharmaceuticals Inc.
$45
Avanir Pharmaceuticals, Inc.
$42
JAZZ PHARMACEUTICALS INC.
$38
Neuronetics, Inc.
$32
Adlon Therapeutics L.P.
$30
Biohaven Pharmaceutical Holding Company Ltd.
$28
Vertical Pharmaceuticals, LLC
$27
Sunovion Pharmaceuticals Inc.
$18
Bausch Health US, LLC
$17
IDORSIA PHARMACEUTICALS US INC
$16
Noven Therapeutics, LLC
$15
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · AJOVY · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · Dyanavel XR · FANAPT · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY SYSTEM · NOCDURNA · NUEDEXTA · NURTEC ODT · Nuedexta · ONGENTYS · Ozempic · QELBREE · QULIPTA · QUVIVIQ · Qelbree · RELEXXII · REXULTI · Rybelsus · SERTRALINE HCL · SPRAVATO · SUNOSI · Saxenda · TRINTELLIX · Trintellix · UBRELVY · VRAYLAR · VYVANSE · WELLBUTRIN · Wegovy · XYOSTED · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for psychiatry in NJ.

Looking for a psychiatry specialist in Ramsey?
Compare psychiatrists in the Ramsey area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
3,663
Per 100K population
383.7
County median income
$123,715
Nearest hospital
RAMAPO RIDGE BEHAVIORAL HEALTH HOSPITAL
4.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Berberian is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement in the top 6% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Berberian experienced with psychotherapy session, 1 hour?
Based on Medicare claims data, Dr. Berberian performed 1,390 psychotherapy session, 1 hour services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berberian receive payments from pharmaceutical companies?
Yes. Dr. Berberian received a total of $7,686 from 34 companies across 550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berberian's costs compare to other psychiatrists in Ramsey?
Dr. Berberian's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berberian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →